Eps Summary of LadRx Corporation

LadRx Corporation's latest annual eps in 2023 was 0.68 USD , up 100.07% from previous year.
LadRx Corporation's latest quarterly eps in 2024 Q2 was -2.59 USD , down -781.58% from previous quarter.
LadRx Corporation reported an annual eps of -968.78 USD in 2022, up 72.37% from previous year.
LadRx Corporation reported an annual eps of -3505.86 USD in 2021, down -81.3% from previous year.
LadRx Corporation reported a quarterly eps of 0.38 USD for 2024 Q1, up 121.97% from previous quarter.
LadRx Corporation reported a quarterly eps of -233.19 USD for 2023 Q1, down -11.23% from previous quarter.

Annual Eps Chart of LadRx Corporation (2023 - 1989)

Historical Annual Eps of LadRx Corporation (2023 - 1989)

Year	Eps	Eps Growth
2023	0.68 USD	100.07%
2022	-968.78 USD	72.37%
2021	-3505.86 USD	-81.3%
2020	-1933.72 USD	10.2%
2019	-2153.42 USD	-5142.02%
2018	-41.08 USD	71.77%
2017	-145.52 USD	61.28%
2016	-375.79 USD	35.34%
2015	-581.19 USD	-74.87%
2014	-332.36 USD	61.63%
2013	-866.24 USD	-84.63%
2012	-469.17 USD	2.77%
2011	-482.54 USD	-2780.78%
2010	18.00 USD	108.93%
2009	-201.66 USD	83.78%
2008	-1243.04 USD	-13.58%
2007	-1094.44 USD	-5.94%
2006	-1033.11 USD	7.35%
2005	-1115.02 USD	44.41%
2004	-2005.90 USD	26.88%
2003	-2743.21 USD	-69.24%
2002	-1620.90 USD	-329.18%
2001	-377.67 USD	-143.36%
2000	-155.19 USD	98.12%
1999	-8259.75 USD	-137.96%
1998	-3471.07 USD	-9.17%
1997	-3179.65 USD	-0.93%
1996	-3150.46 USD	44.44%
1995	-5670.38 USD	-43.6%
1994	-3948.72 USD	-129.27%
1993	-1722.28 USD	-2976.05%
1992	-55.99 USD	-102.78%
1991	2016.00 USD	339.9%
1990	-840.34 USD	82.14%
1989	-4705.88 USD	-31.96%

Year	Eps	Eps Growth
2024 Q2	-2.59 USD	-781.58%
2024 Q1	0.38 USD	121.97%
2023 Q1	-233.19 USD	-11.23%
2023 Q4	-1.73 USD	-4.85%
2023 Q3	-1.65 USD	-125.58%
2023 Q2	6.45 USD	102.77%
2023 FY	- USD	100.07%
2022 FY	- USD	72.37%
2022 Q1	-3.32 USD	86.18%
2022 Q2	-1.79 USD	46.08%
2022 Q4	-209.65 USD	-7994.59%
2022 Q3	-2.59 USD	-44.69%
2021 Q1	-3.51 USD	13.76%
2021 Q3	-4.41 USD	-36.96%
2021 Q2	-3.22 USD	8.26%
2021 Q4	-24.02 USD	-444.67%
2021 FY	- USD	-81.3%
2020 Q2	-4.00 USD	-14.29%
2020 Q4	-4.07 USD	48.35%
2020 Q1	-3.50 USD	61.07%
2020 Q3	-7.88 USD	-97.0%
2020 FY	- USD	10.2%
2019 Q3	-4.43 USD	-15.67%
2019 FY	- USD	-5142.02%
2019 Q4	-8.99 USD	-102.93%
2019 Q2	-3.83 USD	10.72%
2019 Q1	-4.29 USD	43.18%
2018 Q2	-9.94 USD	33.2%
2018 Q3	-9.98 USD	-0.4%
2018 Q4	-7.55 USD	24.35%
2018 Q1	-14.88 USD	19.78%
2018 FY	- USD	71.77%
2017 FY	- USD	61.28%
2017 Q2	-61.95 USD	-6.19%
2017 Q1	-58.34 USD	-25.46%
2017 Q3	-19.25 USD	68.93%
2017 Q4	-18.55 USD	3.64%
2016 Q3	-80.24 USD	50.69%
2016 Q2	-162.74 USD	-42.64%
2016 Q4	-46.50 USD	42.05%
2016 FY	- USD	35.34%
2016 Q1	-114.09 USD	48.43%
2015 Q1	-188.70 USD	-27.25%
2015 Q4	-221.24 USD	-232.84%
2015 FY	- USD	-74.87%
2015 Q2	-125.83 USD	33.32%
2015 Q3	-66.47 USD	47.17%
2014 FY	- USD	61.63%
2014 Q4	-148.29 USD	-144.74%
2014 Q3	-60.59 USD	64.23%
2014 Q2	-169.40 USD	-413.7%
2014 Q1	54.00 USD	113.29%
2013 Q3	-196.70 USD	-191.32%
2013 Q2	-67.52 USD	50.13%
2013 Q4	-406.24 USD	-106.53%
2013 Q1	-135.40 USD	0.0%
2013 FY	- USD	-84.63%
2012 Q3	42.00 USD	111.19%
2012 FY	- USD	2.77%
2012 Q4	- USD	-100.0%
2012 Q1	-286.79 USD	-91.73%
2012 Q2	-375.28 USD	-30.86%
2011 Q3	-17.38 USD	85.51%
2011 FY	- USD	-2780.78%
2011 Q4	-149.58 USD	-760.64%
2011 Q1	-241.33 USD	-251.98%
2011 Q2	-119.98 USD	50.28%
2010 FY	- USD	108.93%
2010 Q1	-23.54 USD	77.26%
2010 Q4	158.79 USD	193.47%
2010 Q2	42.00 USD	278.42%
2010 Q3	-169.88 USD	-504.48%
2009 Q4	-103.51 USD	-161.61%
2009 Q2	-100.14 USD	43.99%
2009 FY	- USD	83.78%
2009 Q1	-178.78 USD	-10.17%
2009 Q3	168.00 USD	267.77%
2008 Q2	-269.59 USD	-7.84%
2008 FY	- USD	-13.58%
2008 Q4	-162.28 USD	71.42%
2008 Q3	-567.77 USD	-110.6%
2008 Q1	-250.00 USD	22.59%
2007 Q4	-322.97 USD	-47.39%
2007 FY	- USD	-5.94%
2007 Q1	-260.56 USD	-1.86%
2007 Q2	-306.68 USD	-17.7%
2007 Q3	-219.12 USD	28.55%
2006 Q4	-255.81 USD	-38.16%
2006 Q2	-328.03 USD	-16.86%
2006 Q3	-185.16 USD	43.55%
2006 Q1	-280.70 USD	-6.59%
2006 FY	- USD	7.35%
2005 Q4	-263.35 USD	-4.47%
2005 Q3	-252.09 USD	23.41%
2005 Q2	-329.13 USD	-18.49%
2005 Q1	-277.76 USD	60.61%
2005 FY	- USD	44.41%
2004 Q1	-463.25 USD	0.0%
2004 Q4	-705.09 USD	-112.01%
2004 Q2	-487.96 USD	-5.33%
2004 Q3	-332.58 USD	31.84%
2004 FY	- USD	26.88%
2003 Q1	-178.48 USD	0.0%
2003 FY	- USD	-69.24%
2003 Q4	- USD	100.0%
2003 Q3	-416.00 USD	51.71%
2003 Q2	-861.46 USD	-382.66%
2002 Q3	-530.98 USD	-58.19%
2002 Q2	-335.67 USD	-394.36%
2002 Q1	-67.90 USD	-106.84%
2002 Q4	- USD	100.0%
2002 FY	- USD	-329.18%
2001 Q3	-409.90 USD	18.39%
2001 Q1	-479.58 USD	-192.67%
2001 Q4	992.55 USD	342.14%
2001 FY	- USD	-143.36%
2001 Q2	-502.27 USD	-4.73%
2000 Q3	-256.21 USD	-22374.56%
2000 Q1	-468.55 USD	79.88%
2000 FY	- USD	98.12%
2000 Q4	517.51 USD	301.99%
2000 Q2	-1.14 USD	99.76%
1999 Q2	-1484.33 USD	18.36%
1999 FY	- USD	-137.96%
1999 Q4	-2328.94 USD	13.59%
1999 Q3	-2695.27 USD	-81.58%
1999 Q1	-1818.18 USD	53.52%
1998 Q4	-3911.85 USD	-240.33%
1998 FY	- USD	-9.17%
1998 Q1	-447.93 USD	53.04%
1998 Q2	1932.00 USD	531.32%
1998 Q3	-1149.43 USD	-159.49%
1997 Q1	-377.97 USD	68.37%
1997 Q4	-953.90 USD	-26.21%
1997 Q3	-755.81 USD	41.93%
1997 Q2	-1301.64 USD	-244.38%
1997 FY	- USD	-0.93%
1996 Q3	-630.01 USD	0.0%
1996 Q2	-630.01 USD	11.75%
1996 Q1	-713.89 USD	32.64%
1996 FY	- USD	44.44%
1996 Q4	-1195.00 USD	-89.68%
1995 Q3	-1008.06 USD	45.44%
1995 Q2	-1847.70 USD	0.01%
1995 Q1	-1847.83 USD	-56.66%
1995 FY	- USD	-43.6%
1995 Q4	-1059.88 USD	-5.14%
1994 Q1	-839.90 USD	21.97%
1994 Q3	-1007.96 USD	0.01%
1994 Q2	-1008.06 USD	-20.02%
1994 FY	- USD	-129.27%
1994 Q4	-1179.49 USD	-17.02%
1993 Q3	-504.03 USD	-372.51%
1993 Q1	106.72 USD	147.65%
1993 Q2	-106.67 USD	-199.95%
1993 Q4	-1076.43 USD	-113.56%
1993 FY	- USD	-2976.05%
1992 Q4	-223.96 USD	-511.62%
1992 Q3	54.41 USD	-67.61%
1992 Q2	168.00 USD	0.0%
1992 Q1	- USD	0.0%
1992 FY	- USD	-102.78%
1991 FY	- USD	339.9%
1991 Q4	- USD	-100.0%
1991 Q1	504.00 USD	0.0%
1991 Q2	1008.00 USD	100.0%
1991 Q3	840.00 USD	-16.67%
1990 Q4	- USD	100.0%
1990 Q3	-168.07 USD	0.0%
1990 Q1	-504.20 USD	67.86%
1990 Q2	- USD	100.0%
1990 FY	- USD	82.14%
1989 FY	- USD	-31.96%
1989 Q3	-598.21 USD	49.13%
1989 Q2	-1176.00 USD	0.0%
1989 Q1	-1176.00 USD	0.0%
1989 Q4	-1568.63 USD	-162.22%

Peer Eps Comparison of LadRx Corporation

Name	Eps	Eps Difference
Burzynski Research Institute, Inc.	-0.01 USD	6766.667%
Arch Therapeutics, Inc.	-2.27 USD	129.956%
Evofem Biosciences, Inc.	10.35 USD	93.43%
Nascent Biotech, Inc.	-0.01 USD	5174.627%
Rebus Holdings, Inc.	-0.03 USD	2218.38%
Santhera Pharmaceuticals Holding AG	5.95 USD	88.571%
Qrons Inc.	-0.06 USD	1266.381%
Adynxx, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	-0.00 USD	45433.333%
Northwest Biotherapeutics, Inc.	-0.06 USD	1282.609%
ProtoKinetix, Incorporated	-0.01 USD	6900.0%
Skye Bioscience, Inc.	-5.37 USD	112.663%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	101.339%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	1420.388%
SQZ Biotechnologies Company	-2.76 USD	124.638%
Intellipharmaceutics International Inc.	-0.09 USD	878.032%
Propanc Biopharma, Inc.	-0.02 USD	2969.198%
Mesoblast Limited	-0.09 USD	863.187%
Marizyme, Inc.	-1.44 USD	147.222%
Genus plc	0.12 USD	-466.667%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	129.185%
Pharming Group N.V.	-0.02 USD	4323.602%
Therapeutic Solutions International, Inc.	-0.00 USD	97242.857%
CNBX Pharmaceuticals Inc.	-0.42 USD	261.905%
Nymox Pharmaceutical Corporation	-0.10 USD	804.663%
ContraFect Corporation	-124.97 USD	100.544%
PsyBio Therapeutics Corp.	-0.04 USD	1719.048%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	5766.667%
IMV Inc.	-4.37 USD	115.561%
AXIM Biotechnologies, Inc.	-0.04 USD	2020.904%
MultiCell Technologies, Inc.	-0.00 USD	680100.0%
ONE Bio Corp.	1.43 USD	52.448%
Accustem Sciences Inc.	-0.34 USD	300.0%
RVL Pharmaceuticals plc	-0.58 USD	217.241%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	-0.12 USD	666.667%
Q BioMed Inc.	-0.08 USD	970.679%
Emmaus Life Sciences, Inc.	-0.07 USD	1067.283%
Mosaic ImmunoEngineering Inc.	-0.33 USD	306.061%
Biomind Labs Inc.	-0.02 USD	4297.531%
American Oriental Bioengineering, Inc.	-781.24 USD	100.087%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	9289.189%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	3517.085%
GlobeStar Therapeutics Corporation	-0.00 USD	28433.333%
THC Farmaceuticals, Inc.	-0.00 USD	85100.0%
Acro Biomedical Co., Ltd.	-0.26 USD	361.538%
Curative Biotechnology, Inc.	-0.01 USD	7827.273%
GB Sciences, Inc.	-0.00 USD	16685.366%
Alpha Cognition Inc.	-0.15 USD	553.333%
HST Global, Inc.	-0.03 USD	2537.276%
CSL Limited	2.73 USD	75.092%
Wesana Health Holdings Inc.	-0.05 USD	1457.285%
Halberd Corporation	-0.00 USD	680100.0%
Enzolytics Inc.	-0.00 USD	97242.857%
Agentix Corp.	-0.04 USD	2042.857%
Resverlogix Corp.	-0.01 USD	4888.732%
Nuo Therapeutics, Inc.	-0.08 USD	1001.857%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	-5.16 USD	113.178%
Enzon Pharmaceuticals, Inc.	0.00 USD	-52207.692%
Endonovo Therapeutics, Inc.	0.03 USD	-2609.163%
RespireRx Pharmaceuticals Inc.	-0.04 USD	2004.762%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	3500.0%
AVAX Technologies, Inc.	-0.05 USD	1361.596%
Zenith Capital Corp.	-0.07 USD	1072.818%
Genscript Biotech Corporation	-0.05 USD	1597.797%
Ember Therapeutics, Inc.	-0.01 USD	10893.651%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	118.037%
WPD Pharmaceuticals Inc.	-0.00 USD	136100.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	844.797%
Kadimastem Ltd	-0.78 USD	187.179%
Helix BioMedix, Inc.	-4.70 USD	114.468%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	-36.39 USD	101.869%
BioStem Technologies, Inc.	-0.62 USD	209.677%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	-0.01 USD	5814.286%
Cell Source, Inc.	-0.17 USD	500.0%
Regen BioPharma, Inc.	0.29 USD	-134.483%
Regen BioPharma, Inc.	0.26 USD	-161.538%
NovAccess Global Inc.	-0.23 USD	395.652%
Affymax, Inc.	-0.39 USD	274.359%
Itoco Inc.	-0.01 USD	9047.368%
Rasna Therapeutics, Inc.	-0.01 USD	6900.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	27300.0%
Mobile Lads Corp.	-0.01 USD	12242.857%
CytoDyn Inc.	-0.05 USD	1385.444%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	136100.0%
NanoSphere Health Sciences Inc.	-0.02 USD	3163.063%
Alseres Pharmaceuticals, Inc.	-153.67 USD	100.443%
SYBLEU INC	-0.02 USD	3985.714%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	4888.732%
International Stem Cell Corporation	-0.02 USD	4246.341%
Bioxytran, Inc.	-0.03 USD	2231.661%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	-0.00 USD	680100.0%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	-7.99 USD	108.511%
Adhera Therapeutics, Inc.	-1.18 USD	157.627%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	-0.03 USD	2100.0%
Innovation Pharmaceuticals Inc.	-0.01 USD	10893.651%
Neutra Corp.	-0.00 USD	680100.0%
Windtree Therapeutics, Inc.	-94.23 USD	100.722%
PureTech Health plc	-2.38 USD	128.571%
Coeptis Therapeutics, Inc.	-0.83 USD	181.928%
IXICO plc	-0.02 USD	2886.885%
IntelGenx Technologies Corp.	-0.06 USD	1297.183%
Gelesis Holdings, Inc.	-1.35 USD	150.37%
CSL Limited	5.47 USD	87.569%
Cellectis S.A.	-1.77 USD	138.418%

Global Stocks Search

LadRx Corporation (LADX)

Eps Summary of LadRx Corporation

Annual Eps Chart of LadRx Corporation (2023 - 1989)

Historical Annual Eps of LadRx Corporation (2023 - 1989)

Peer Eps Comparison of LadRx Corporation